Terms: = Liver cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
1481 results:
1. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
Qiao W; Li J; Xiong Y; Zheng J; Jin R; Hu C
J Cancer Res Clin Oncol; 2024 May; 150(5):241. PubMed ID: 38713414
[TBL] [Abstract] [Full Text] [Related]
2. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
[TBL] [Abstract] [Full Text] [Related]
3. [Fonction de l'ARNnc exosomal HEIH dans le carcinome hépatocellulaire associé au virus de l'hépatite B].
Yu T; Li H; Shen G; Wu Q
Ann Biol Clin (Paris); 2024 Apr; 82(1):93-102. PubMed ID: 38638022
[TBL] [Abstract] [Full Text] [Related]
4. Long noncoding RNA small nucleolar RNA host genes as prognostic molecular biomarkers in hepatocellular carcinoma: A meta-analysis.
Huang M; Zhao Z; Yang L
Cancer Med; 2024 Apr; 13(8):e7200. PubMed ID: 38634194
[TBL] [Abstract] [Full Text] [Related]
5. Alpha-fetoprotein: Past, present, and future.
Yeo YH; Lee YT; Tseng HR; Zhu Y; You S; Agopian VG; Yang JD
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38619448
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
Yang LM; Wang HJ; Li SL; Gan GH; Deng WW; Chang YS; Zhang LF
World J Gastroenterol; 2024 Mar; 30(11):1533-1544. PubMed ID: 38617449
[TBL] [Abstract] [Full Text] [Related]
7. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
[TBL] [Abstract] [Full Text] [Related]
8. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
9. Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma.
Hou C; Xiong B; Zhou L; Fei Y; Shi C; Zhu X; Xie T; Wu Y
BMC Cancer; 2024 Mar; 24(1):387. PubMed ID: 38539150
[TBL] [Abstract] [Full Text] [Related]
10. Clinical significance of small nuclear ribonucleoprotein U1 subunit 70 in patients with hepatocellular carcinoma.
Jiang D; Zhu XL; An Y; Li YR
PeerJ; 2024; 12():e16876. PubMed ID: 38500533
[TBL] [Abstract] [Full Text] [Related]
11. The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma.
Lee JH; Hong YM
BMC Cancer; 2024 Mar; 24(1):327. PubMed ID: 38462640
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
Kaneko S; Asahina Y; Murakawa M; Azuma S; Inada K; Mochida T; Watakabe K; Shimizu T; Tsuchiya J; Miyoshi M; Kawai-Kitahata F; Nitta S; Takahashi M; Fujioka T; Kishino M; Anzai T; Kakinuma S; Nakagawa M; Okamoto R
PLoS One; 2024; 19(3):e0297882. PubMed ID: 38452155
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of survival and analysis of prognostic factors for patients with afp negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
14. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract] [Full Text] [Related]
15. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract] [Full Text] [Related]
16. Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma.
Gil-Rojas S; Suárez M; Martínez-Blanco P; Torres AM; Martínez-García N; Blasco P; Torralba M; Mateo J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396674
[TBL] [Abstract] [Full Text] [Related]
17. Proteomic Analysis Identifies GSN as a Noninvasive Circulating Serum Biomarker for Predicting Early Recurrence of Hepatocellular Carcinoma.
Hu E; Yang T; Cai L; Ouyang J; Wang F; Li Z; Wang Y; Xing X; Liu X
J Proteome Res; 2024 Mar; 23(3):1062-1074. PubMed ID: 38373391
[TBL] [Abstract] [Full Text] [Related]
18. An AgPd NP-based lateral flow immunoassay for simultaneous detection of glycocholic acid and alpha-fetoprotein.
Jiang S; Chen Y; Liang J; Xiao H; Lin M; Cui X; Zhao S
Anal Methods; 2024 Mar; 16(10):1508-1514. PubMed ID: 38372146
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
[TBL] [Abstract] [Full Text] [Related]
20. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract] [Full Text] [Related]
[Next]